Medication and ICDs for dilated cardiomyopathy
Part of Heart & circulation clinical trials.
This trial tests whether combining modern heart failure medications with an implantable defibrillator (ICD) can reduce the risk of dangerous heart rhythms and improve survival in people with dilated cardiomyopathy. It focuses on those with a weak heart pump and specific scarring seen on MRI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of heart muscle disease called dilated cardiomyopathy (not caused by blocked arteries)
- An MRI of your heart shows certain scarring (called late gadolinium enhancement), but not the hinge-point type
- Your heart's pumping strength is less than 35% (measured by an echo or MRI)
- Your heart failure symptoms are mild to moderate (NYHA class I, II, or III)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether implanting a defibrillator (ICD) soon after a heart attack can lower the risk of sudden cardiac death in people with weaker heart pumping and symptoms of heart failure. It compares strategies around defibrillator implantation, aiming to improve safety and outcomes.
This trial tests whether using an MRI to guide the placement of a defibrillator (ICD) helps people with weak hearts. It might offer a more precise way to implant the device.
This trial tests whether a programmed heart rhythm test can better identify who needs an implanted defibrillator (ICD) soon after a heart attack. It may help prevent dangerous fast heart rhythms (tachyarrhythmias) by guiding who gets an ICD.
This study looks at whether using a heart MRI (CMR) to guide where to place an implanted defibrillator (ICD) improves outcomes for people with a weakened heart muscle caused by non-ischemic dilated cardiomyopathy. It’s for adults who have low pumping strength and evidence of heart scarring on MRI.
This study tests whether using a special heart MRI to guide the placement of an implantable defibrillator (ICD) is safe and effective in people with dilated, non-ischemic cardiomyopathy and reduced heart pumping. It may help improve how accurately the device is positioned and support better care planning.
This trial is testing a personalized approach to deciding who gets an implantable defibrillator (ICD) for people with heart failure due to dilated cardiomyopathy (not from blocked arteries). It aims to see if MRI scans and other factors can better match the device to those who need it most.
Hear when a new Sudden Cardiac Death trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.